vs

Side-by-side financial comparison of Enovis CORP (ENOV) and Legence Corp. (LGN). Click either name above to swap in a different company.

Legence Corp. is the larger business by last-quarter revenue ($708.0M vs $589.2M, roughly 1.2× Enovis CORP). Legence Corp. runs the higher net margin — -0.1% vs -1.4%, a 1.4% gap on every dollar of revenue. On growth, Legence Corp. posted the faster year-over-year revenue change (26.2% vs 5.4%).

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

Legence Corp is a leading sustainable building and decarbonization solution provider. It delivers energy efficiency optimization, building automation design, renewable energy integration, and low-carbon retrofit services for commercial, industrial, and institutional clients, with core operations across North America to help customers cut costs and reduce carbon footprints.

ENOV vs LGN — Head-to-Head

Bigger by revenue
LGN
LGN
1.2× larger
LGN
$708.0M
$589.2M
ENOV
Growing faster (revenue YoY)
LGN
LGN
+20.8% gap
LGN
26.2%
5.4%
ENOV
Higher net margin
LGN
LGN
1.4% more per $
LGN
-0.1%
-1.4%
ENOV

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
ENOV
ENOV
LGN
LGN
Revenue
$589.2M
$708.0M
Net Profit
$-8.4M
$-576.0K
Gross Margin
62.0%
20.9%
Operating Margin
5.3%
Net Margin
-1.4%
-0.1%
Revenue YoY
5.4%
26.2%
Net Profit YoY
46.8%
EPS (diluted)
$-0.15
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENOV
ENOV
LGN
LGN
Q1 26
$589.2M
Q4 25
$548.9M
Q3 25
$564.5M
$708.0M
Q2 25
$558.8M
Q4 24
$561.0M
Q3 24
$505.2M
$560.8M
Q2 24
$525.2M
Net Profit
ENOV
ENOV
LGN
LGN
Q1 26
$-8.4M
Q4 25
$-571.1M
Q3 25
$-36.7M
$-576.0K
Q2 25
$-56.0M
Q4 24
$-703.2M
Q3 24
$-31.5M
$-1.1M
Q2 24
$-18.6M
Gross Margin
ENOV
ENOV
LGN
LGN
Q1 26
62.0%
Q4 25
59.9%
Q3 25
59.3%
20.9%
Q2 25
59.5%
Q4 24
54.8%
Q3 24
56.7%
21.1%
Q2 24
55.0%
Operating Margin
ENOV
ENOV
LGN
LGN
Q1 26
Q4 25
-101.7%
Q3 25
-3.0%
5.3%
Q2 25
-8.4%
Q4 24
-118.5%
Q3 24
-6.3%
4.8%
Q2 24
-8.4%
Net Margin
ENOV
ENOV
LGN
LGN
Q1 26
-1.4%
Q4 25
-104.1%
Q3 25
-6.5%
-0.1%
Q2 25
-10.0%
Q4 24
-125.4%
Q3 24
-6.2%
-0.2%
Q2 24
-3.5%
EPS (diluted)
ENOV
ENOV
LGN
LGN
Q1 26
$-0.15
Q4 25
$-9.99
Q3 25
$-0.64
$-0.02
Q2 25
$-0.98
Q4 24
$-12.69
Q3 24
$-0.58
Q2 24
$-0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENOV
ENOV
LGN
LGN
Cash + ST InvestmentsLiquidity on hand
$33.1M
$176.0M
Total DebtLower is stronger
$1.3B
$812.6M
Stockholders' EquityBook value
$1.5B
$387.9M
Total Assets
$3.8B
$2.6B
Debt / EquityLower = less leverage
0.90×
2.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENOV
ENOV
LGN
LGN
Q1 26
$33.1M
Q4 25
$33.6M
Q3 25
$44.1M
$176.0M
Q2 25
$38.5M
Q4 24
$48.2M
Q3 24
$35.4M
Q2 24
$35.0M
Total Debt
ENOV
ENOV
LGN
LGN
Q1 26
$1.3B
Q4 25
$1.4B
Q3 25
$1.4B
$812.6M
Q2 25
$1.4B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.3B
Stockholders' Equity
ENOV
ENOV
LGN
LGN
Q1 26
$1.5B
Q4 25
$2.0B
Q3 25
$2.6B
$387.9M
Q2 25
$2.6B
Q4 24
$2.6B
Q3 24
$3.3B
Q2 24
$3.3B
Total Assets
ENOV
ENOV
LGN
LGN
Q1 26
$3.8B
Q4 25
$4.4B
Q3 25
$5.0B
$2.6B
Q2 25
$4.9B
Q4 24
$4.7B
Q3 24
$5.6B
Q2 24
$5.4B
Debt / Equity
ENOV
ENOV
LGN
LGN
Q1 26
0.90×
Q4 25
0.67×
Q3 25
0.54×
2.10×
Q2 25
0.53×
Q4 24
0.52×
Q3 24
0.40×
Q2 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENOV
ENOV
LGN
LGN
Operating Cash FlowLast quarter
$162.1M
Free Cash FlowOCF − Capex
$137.4M
FCF MarginFCF / Revenue
19.4%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENOV
ENOV
LGN
LGN
Q1 26
Q4 25
$82.6M
Q3 25
$47.8M
$162.1M
Q2 25
$-1.6M
Q4 24
$88.3M
Q3 24
$53.6M
Q2 24
$7.8M
Free Cash Flow
ENOV
ENOV
LGN
LGN
Q1 26
Q4 25
$29.1M
Q3 25
$3.4M
$137.4M
Q2 25
$-44.9M
Q4 24
$35.1M
Q3 24
$2.4M
Q2 24
$-31.6M
FCF Margin
ENOV
ENOV
LGN
LGN
Q1 26
Q4 25
5.3%
Q3 25
0.6%
19.4%
Q2 25
-8.0%
Q4 24
6.3%
Q3 24
0.5%
Q2 24
-6.0%
Capex Intensity
ENOV
ENOV
LGN
LGN
Q1 26
Q4 25
9.7%
Q3 25
7.9%
3.5%
Q2 25
7.7%
Q4 24
9.5%
Q3 24
10.1%
Q2 24
7.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENOV
ENOV

Segment breakdown not available.

LGN
LGN

Installation And Fabrication$408.7M58%
Engineering And Design$110.9M16%
Program And Project Management$101.2M14%
Maintenance And Service$87.1M12%

Related Comparisons